Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice.

Saved in:
Bibliographic Details
Title: Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice.
Authors: Morel KL; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, South Australia, Australia., Germán B; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Walter Reed National Military Medical Center, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, Maryland, USA.; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Hamid AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia., Nanda JS; Division of Hematology and Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA., Linder S; Division of Oncogenomics, Oncode Institute., Bergman AM; Division of Oncogenomics, Oncode Institute.; Division of Medical Oncology., van der Poel H; Division of Urology., Hofland I; Core Facility Molecular Pathology and Biobanking; and., Bekers EM; Division of Pathology; Netherlands Cancer Institute, Amsterdam, Netherlands., Trostel SY; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Burkhart DL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Wilkinson S; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Ku AT; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Kim M; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA., Kim J; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA., Ma D; David H. Koch Institute for Integrative Cancer Research, Bioinformatics and Computing Facility of Swanson Biotechnology Center, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Plummer JT; Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., You S; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, USA., Su XA; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Walter Reed National Military Medical Center, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, Maryland, USA.; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.; David H. Koch Institute for Integrative Cancer Research, Bioinformatics and Computing Facility of Swanson Biotechnology Center, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Zwart W; Division of Oncogenomics, Oncode Institute., Sowalsky AG; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Sweeney CJ; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, South Australia, Australia.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Ellis L; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Walter Reed National Military Medical Center, Bethesda, Maryland, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, Maryland, USA.; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Source: The Journal of clinical investigation [J Clin Invest] 2024 Nov 19; Vol. 135 (2). Date of Electronic Publication: 2024 Nov 19.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-8238
DOI:10.1172/JCI175680